To obtain both arterial and venous phases within a single contrast scan, a phased administration of contrast agent was performed.
Laboratory tests of the anti-cracking agent were performed, and test roads in the field were evaluated.
Afterwards, a tensile strength characterisation for 20 50% w/w LCN contents with the same amount of coupling agent was performed.
Addition of maleic anhydride grafted polypropylene (MAPP) as coupling agent was performed to promote polymer/fiber interfacial adhesion.
Multiphase acquisitions after the administration of hepatospecific contrast agent are performed; when clinically indicated, a late scan in the excretory phase is performed to evaluate the biliary system.
In order to confirm the presence of a siccative oil, GC/MS analyses after saponification, extraction and derivatisation with a silanising agent, were performed.
The green synthesis of AuNPs with caffeic acid as a reducing agent was performed under a fixed final concentration (0.2 mM) of hydrochloroauric acid trihydrate.
NOx reduction from gas stream by selective non-catalytic reduction (SNCR) using urea as a reducing agent was performed in this study.
Depending on the clinical situation and the availability of previous CT examinations, either a diagnostic CT including the application of intravenous contrast media or a low-dose CT without contrast agent was performed.
To optimize the SERS samples preparation, a design of experiments implicating concentrations of citrate-reduced silver nanoparticles and aggregating agent was performed in order to maximize the Raman signal enhancement.
